Behavioral disorders, learning disabilities and megavitamin therapy.
During the 1970s, vitamins and vitamin therapy became household words. Vitamin therapy, better known as "orthomolecular psychiatry," is both appealing and very popular. The question that must be asked is: Does this popularity and appeal validate this form of therapy? This paper presents findings from various sources that give results of research in megavitamin nutritional therapy. The following categories are examined: learning disabilities in general, schizophrenia, autism, mental retardation and Down's syndrome, and hyperkinesis.
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001321:Autistic Disorder / Q000188:drug therapy; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004314:Down Syndrome / Q000188:drug therapy; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D007859:Learning Disabilities / Q000188:drug therapy*; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy; D014815:Vitamins / Q000627:therapeutic use*
D014815:Vitamins